Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.04%
#2 Ocean Protocol Ocean Protocol +22.42%
#3 Audiera Audiera +15.20%
#4 Geodnet Geodnet +14.73%
#5 Arowana Arowana +7.85%
#6 DexNet DexNet +7.78%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.71%
#8 Ontology Gas Ontology Gas +6.77%
#9 Rollbit Coin Rollbit Coin +6.27%
#10 Cysic Cysic +6.18%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
株式のランク #32249
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
株価
$0.8013
最終同期: 2026-08-05
時価総額
$10.62M
変化（1日）
0.97%
変化（1年）
-37.88%
国
US
取引 Hoth Therapeutics, Inc. (HOTH)

カテゴリー

Healthcare
Hoth Therapeutics, Inc.（HOTH）のEPS
2026 時点のEPS TTM: 0
Hoth Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Hoth Therapeutics, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR